Reno Gazette Journal Esai and Biogen, Leqembi manufacturer, receive FDA approval for Alzheimer's drug Northern Sierra • Jul 7, 2023
Daily Mail on Nevada Eisai, Biogen say Alzheimer's drug succeeds in slowing cognitive decline Nevada Non-Local Sources • Sep 28, 2022
Elko Daily Biogen's 2022 outlook leaves investors wanting, shares slip Northeast Nevada • Feb 3, 2022
Elko Daily Biogen tumbles after Medicare lays out Aduhelm coverage plan Northeast Nevada • Jan 12, 2022
Elko Daily Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug Northeast Nevada • Oct 20, 2021
Daily Mail on Nevada Biogen shares rise as FDA nears ruling on controversial Alzheimer's drug Nevada Non-Local Sources • Jun 7, 2021
Daily Mail on Nevada U.S. FDA set to rule on controversial Biogen Alzheimer's drug Nevada Non-Local Sources • Jun 7, 2021
Elko Daily How Biogen Salvaged Its Alzheimer's Drug After a Costly Failure Northeast Nevada • Oct 23, 2019
Las Vegas Sun Biogen reanalyzes studies, presses ahead on Alzheimer's drug Southern Nevada • Oct 22, 2019
Vegas, Inc. Biogen reanalyzes studies, presses ahead on Alzheimer's drug Nevada Business • Oct 22, 2019
KTVN Channel 2 Reno Company Says It Will Seek Federal Approval of Alzheimer's Drug Northern Sierra • Oct 22, 2019